Camilo Oñate‐Schneider
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Camilo Oñate‐Schneider has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Carolina De la Fuente
Escuela de Salud Pública, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
1 shared publication - Cristian Rebolledo Díaz
Escuela de Salud Pública, Universidad de Chile, Santiago, Chile
1 shared publication - Javiera Leniz
Pontificia Universidad Católica de Chile
1 shared publication - Oscar Arteaga
Universidad de Chile, Chile
1 shared publication - Paula Bedregal
Pontificia Universidad Católica de Chile
1 shared publication - Paula Zamorano
Innovación ANCORA UC, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
1 shared publication
Latest Publications
- 20 February 2026
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (4) , 1163-1172
Quality of Care Indicators for People With Dementia: An Umbrella Review
Background: Monitoring the dementia care quality is key for healthcare services. Dementia care quality indicators (QIs) have been reported in the literature, fragmented by setting or stage of care. We aimed to conduct an umbrella review (review of systematic reviews) to identify, evaluate, and summarize dementia care QIs throughout the disease trajectory. Methods: We conducted an umbrella review reporting the development, review, or testing of dementia care QIs. We used a structured search in MEDLINE (Ovid), PsycINFO (EBSCO), Cochrane Library, and LILACS. Two researchers independently screened titles, abstracts, and full‐texts. QIs from included articles were extracted by one reviewer and checked by a second one. The AMSTAR 2 and AIRE tools were used to assess the methodological quality of reviews and QIs, respectively. Included QIs were categorized and coded based on their stage of care (initial assessment after diagnosis, follow‐up and treatment, and end‐of‐life), type of indicator (structure, process, outcome), and specific aspects of care measured. Results: Six systematic reviews were included, comprising 554 dementia care QIs that were synthesized into 120 QIs. 86 (72%) were classified as process, 20 (16%) as structure, and 14 (12%) as outcome indicators. 32 QIs (27%) are recommended exclusively for community settings, 7 (6%) for hospital settings, and 81 (67%) for more than one care setting. The 120 QIs are related to 60 different aspects of care, with advanced care planning and having an individualized healthcare plan being the most frequently quoted QIs. The quality of systematic reviews was low to critically low, and over a third of QIs were considered to have high methodological quality. Conclusions: Our umbrella review synthesized a broad overview of dementia care QIs, facilitating healthcare organizations to monitor and improve areas in need. Future research should focus on validating these QIs in local contexts.
- 20 February 2026
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (4) , 1163-1172
Quality of Care Indicators for People With Dementia: An Umbrella Review
Background: Monitoring the dementia care quality is key for healthcare services. Dementia care quality indicators (QIs) have been reported in the literature, fragmented by setting or stage of care. We aimed to conduct an umbrella review (review of systematic reviews) to identify, evaluate, and summarize dementia care QIs throughout the disease trajectory. Methods: We conducted an umbrella review reporting the development, review, or testing of dementia care QIs. We used a structured search in MEDLINE (Ovid), PsycINFO (EBSCO), Cochrane Library, and LILACS. Two researchers independently screened titles, abstracts, and full‐texts. QIs from included articles were extracted by one reviewer and checked by a second one. The AMSTAR 2 and AIRE tools were used to assess the methodological quality of reviews and QIs, respectively. Included QIs were categorized and coded based on their stage of care (initial assessment after diagnosis, follow‐up and treatment, and end‐of‐life), type of indicator (structure, process, outcome), and specific aspects of care measured. Results: Six systematic reviews were included, comprising 554 dementia care QIs that were synthesized into 120 QIs. 86 (72%) were classified as process, 20 (16%) as structure, and 14 (12%) as outcome indicators. 32 QIs (27%) are recommended exclusively for community settings, 7 (6%) for hospital settings, and 81 (67%) for more than one care setting. The 120 QIs are related to 60 different aspects of care, with advanced care planning and having an individualized healthcare plan being the most frequently quoted QIs. The quality of systematic reviews was low to critically low, and over a third of QIs were considered to have high methodological quality. Conclusions: Our umbrella review synthesized a broad overview of dementia care QIs, facilitating healthcare organizations to monitor and improve areas in need. Future research should focus on validating these QIs in local contexts.
- 27 August 2025
- Published by Medwave Estudios Limitada in Medwave
- Vol. 25 (07) , e3070
Characterization of the expressed and effective demand for oncology services under the explicit health guarantees of the Chilean public health system
Introduction Efficient and effective cancer management is a priority for the Chilean healthcare system. In recent years, significant progress has been made through public policies integrating management at different levels (micro, meso, and macro). However, gaps between the population’s needs, service availability, and effective demand may impact health outcomes. Objective To describe the national effective demand for prioritized cancer services within the Chilean public healthcare system. Methods A descriptive comparative analysis was conducted using data from the public sector Health Guarantees Management Information System between 2018 and 2022. The rates of new cases granted health guarantees by intervention type and the analysis of delayed guarantees were performed. Results A total of 3.8 million new cases of explicit health guarantees and 3.9 million fulfilled opportunity guarantees were included. The rates of primary treatment opportunity guarantee by tracer intervention declined in 2020 and 2021, while delayed guarantees showed an increasing trend throughout the entire period. Effective demand varied across cancer types. Breast cancer, preventive cholecystectomy, and gastric cancer exhibited the largest sex-based differences in new cases and primary treatment. Delayed guarantees were similar between sexes, except for breast cancer. Conclusions This study provides valuable insights into the demand for cancer services in Chile and the performance of the public healthcare system concerning sex and cancer type, highlighting the impact of the COVID-19 pandemic. The findings emphasize the need to strengthen the public system’s response capacity to reduce gaps and improve equity in oncological care.
- 27 August 2025
- Published by Medwave Estudios Limitada in Medwave
- Vol. 25 (07) , e3070
Characterization of the expressed and effective demand for oncology services under the explicit health guarantees of the Chilean public health system
Introduction Efficient and effective cancer management is a priority for the Chilean healthcare system. In recent years, significant progress has been made through public policies integrating management at different levels (micro, meso, and macro). However, gaps between the population’s needs, service availability, and effective demand may impact health outcomes. Objective To describe the national effective demand for prioritized cancer services within the Chilean public healthcare system. Methods A descriptive comparative analysis was conducted using data from the public sector Health Guarantees Management Information System between 2018 and 2022. The rates of new cases granted health guarantees by intervention type and the analysis of delayed guarantees were performed. Results A total of 3.8 million new cases of explicit health guarantees and 3.9 million fulfilled opportunity guarantees were included. The rates of primary treatment opportunity guarantee by tracer intervention declined in 2020 and 2021, while delayed guarantees showed an increasing trend throughout the entire period. Effective demand varied across cancer types. Breast cancer, preventive cholecystectomy, and gastric cancer exhibited the largest sex-based differences in new cases and primary treatment. Delayed guarantees were similar between sexes, except for breast cancer. Conclusions This study provides valuable insights into the demand for cancer services in Chile and the performance of the public healthcare system concerning sex and cancer type, highlighting the impact of the COVID-19 pandemic. The findings emphasize the need to strengthen the public system’s response capacity to reduce gaps and improve equity in oncological care.